Acrigen Biosciences Alternatives & Competitors
12 companies similar to Acrigen Biosciences — Developing life-saving genetic therapies using our proprietary precision gene ed...
Companies similar to Acrigen Biosciences
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based techn...
Cambridge, United States
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Cambridge, United States
Moonwalk Biosciences
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and ep...
South San Francisco, Unit...
Tessera Therapeutics
Pioneering the future of genetic medicine with the power to rewrite the genome and cure di...
Rival Readout
Competing with Acrigen Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Korea South
HuidaGene Therapeutics
辉大，给患者回答 | Answering the Patients！
Shanghai, China
Renovacor
Advancing transformative therapies for cardiovascular disease
Recombinetics
Delivering the Next Evolution of Healthcare
Eagan, United States
Ordaos Bio
Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments.
New York, United States
LifeMap Sciences
Leading biomedical knowledgebases and clinical genetics analysis solutions
Alameda, United States
Synthego
Your Partner in CRISPR & Molecular Diagnostics
Menlo Park, United States
Mammoth Biosciences
Improving lives by reading and writing the code of life.
Brisbane, United States
About Acrigen Biosciences
Acrigen Biosciences, founded in 2019, is a pioneering life science startup based in Berkeley, California. With a focus on biotechnology and life sciences, the company stands out for its mission to develop life-saving genetic therapies using its proprietary precision gene editing technology. Co-founded by Dr.
Development of Precision Gene Editing Systems, Licensing of CRISPR-Cas Nuclease Library, ErAcr Proteins for Precision Enhancement
Biopharmaceutical Companies, Medical Research Institutions, Healthcare Providers, Biotechnology Firms
Gene Editing, CRISPR-Cas Technology, Genetic Therapies, Anti-CRISPR Proteins, Precision Medicine, Genetic Disorders, Life Sciences, Therapeutic Pipeline, Biomedical Innovation, Safety Enhancement, Efficacy Improvement, Novel Biotechnologies, Disease Prevention
B2B, Platform
Licensing, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Acrigen Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Acrigen Biosciences on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
